Tudóstér: Pályiné dr Krekk Zsuzsanna publikációi

Pályiné Krekk, Z.: Molekuláris gerontológia napjainkban.
Magy. gerontol. 13 (40), 116-126, 2021.

Roszik, J., Sebestyén, Z., Govers, C., Guri, Y., Szöőr, Á., Pályiné Krekk, Z., Vereb, G., Nagy, P., Szöllősi, J., Debets, R.: T-cell synapse formation depends on antigen recognition but not CD3 interaction: studies with TCR : zeta, a candidate transgene for TCR gene therapy.
Eur. J. Immunol. 41 (5), 1288-1297, 2011.

Pályiné Krekk, Z., Barok, M., Kovács, T., Saya, H., Nagano, O., Szöllősi, J., Nagy, P.: EGFR and ErbB2 are functionally coupled to CD44 and regulate shedding, internalization and motogenic effect of CD44.
Cancer Lett. 263 (2), 231-242, 2008.

Szöllősi, J., Vereb, G., Barok, M., Pályiné Krekk, Z., Nagy, P.: Role of Egf receptor tyrosine kinases in breast cancer: a biophysical approach.
Cytometry B. 74B (6), 385, 2008.

Fazekas, Z., Petrás, M., Fábián, Á., Pályiné Krekk, Z., Nagy, P., Damjanovich, S., Vereb, G., Szöllősi, J.: Two-sided fluorescence resonance energy transfer for assessing molecular interactions of up to three distinct species in confocal microscopy.
Cytom. Part A. 73 (3), 209-219, 2008.

Pályiné Krekk, Z., Barok, M., Isola, J., Tammi, M., Szöllősi, J., Nagy, P.: Hyaluronan-induced masking of ErbB2 and CD44-enhanced trastuzumab internalisation in trastuzumab resistant breast cancer.
Eur. J. Cancer. 43 (16), 2423-2433, 2007.

Barok, M., Isola, J., Pályiné Krekk, Z., Nagy, P., Juhász, I., Vereb, G., Kauraniemi, P., Kapanen, A., Tanner, M., Vereb, G., Szöllősi, J.: Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance.
Mol. Cancer Ther. 6 (7), 2065-2072, 2007.